Doctor Matthew
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Doctor Matthew. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RGS | President and CEO | Award / Grant | 16,500 | — | — | Nov 22, 2024 |
| RGS | President and CEO | Tax Withholding | 547 | $23.37 | $12,783 | Nov 5, 2024 |
| RGS | President and CEO | Tax Withholding | 339 | $23.37 | $7,922 | Nov 5, 2024 |
| RGS | President and CEO | Tax Withholding | 211 | $12.35 | $2,606 | Feb 8, 2024 |
| RGS | President and CEO | Tax Withholding | 3,648 | $0.53 | $1,933 | Nov 6, 2023 |
| RGS | President and CEO | Tax Withholding | 2,837 | $1.26 | $3,575 | Nov 7, 2022 |
| RGS | Interim CEO | Tax Withholding | 4,343 | $1.65 | $7,166 | Feb 8, 2022 |
| RGS | EVP, Chief Strategy Officer | Award / Grant | 46,344 | — | — | Nov 5, 2021 |
| RGS | EVP, Chief Strategy Officer | Award / Grant | 34,758 | — | — | Nov 5, 2021 |
| RGS | EVP, Chief Strategy Officer | Award / Grant | 28,382 | — | — | Feb 8, 2021 |